Cas no 1189112-05-7 (HO-PEG14-OH)
HO-PEG14-OH Chemical and Physical Properties
Names and Identifiers
-
- PEG-14
- HO-14-OH
- HO-dPEG14-OH
- PEG15
- tetradecaethylene glycol
- 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol
- Q27464382
- 3,6,9,12,15,18,21,24,27,30,33,36,39-Tridecaoxahentetracontane-1,41-diol
- HO-PEG14-OH
-
- Inchi: 1S/C28H58O15/c29-1-3-31-5-7-33-9-11-35-13-15-37-17-19-39-21-23-41-25-27-43-28-26-42-24-22-40-20-18-38-16-14-36-12-10-34-8-6-32-4-2-30/h29-30H,1-28H2
- InChI Key: ILLKMACMBHTSHP-UHFFFAOYSA-N
- SMILES: O(CCOCCOCCOCCOCCOCCOCCO)CCOCCOCCOCCOCCOCCOCCO
Computed Properties
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 15
- Heavy Atom Count: 43
- Rotatable Bond Count: 40
- Complexity: 439
- Topological Polar Surface Area: 160
Experimental Properties
- Density: 1.116±0.06 g/cm3 (20 oC 760 Torr),
- Solubility: Extremely soluble (1000 g/l) (25 o C),
HO-PEG14-OH Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | BP-21969-5g |
PEG15 |
1189112-05-7 | >97% | 5g |
13395CNY | 2021-05-07 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | BP-21969-1g |
PEG15 |
1189112-05-7 | >97% | 1g |
4702CNY | 2021-05-07 | |
| S e l l e c k ZHONG GUO | S1948-100mg |
HO-PEG14-OH |
1189112-05-7 | 100mg |
¥2470.73 | 2022-04-26 | ||
| TRC | H456405-50mg |
HO-PEG14-OH |
1189112-05-7 | 50mg |
$276.00 | 2023-05-18 | ||
| TRC | H456405-100mg |
HO-PEG14-OH |
1189112-05-7 | 100mg |
$385.00 | 2023-05-18 | ||
| TRC | H456405-250mg |
HO-PEG14-OH |
1189112-05-7 | 250mg |
$523.00 | 2023-05-18 | ||
| TRC | H456405-500mg |
HO-PEG14-OH |
1189112-05-7 | 500mg |
$758.00 | 2023-05-18 | ||
| TRC | H456405-1g |
HO-PEG14-OH |
1189112-05-7 | 1g |
$ 965.00 | 2022-06-04 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | BP-21969-5g |
PEG15 |
1189112-05-7 | >97% | 5g |
13395.0CNY | 2021-07-10 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | BP-21969-1g |
PEG15 |
1189112-05-7 | >97% | 1g |
4702.0CNY | 2021-07-10 |
HO-PEG14-OH Suppliers
HO-PEG14-OH Related Literature
-
Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
-
Robert P. Davies,Maria A. Giménez,Laura Patel,Andrew J. P. White Dalton Trans., 2008, 5705-5707
-
3. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disordersJie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
-
Yuan-Jun Tong,Lu-Dan Yu,Lu-Lu Wu,Shu-Ping Cao,Ru-Ping Liang,Li Zhang,Xing-Hua Xia,Jian-Ding Qiu Chem. Commun., 2018,54, 7487-7490
Additional information on HO-PEG14-OH
Comprehensive Overview of HO-PEG14-OH (CAS No. 1189112-05-7): Properties, Applications, and Innovations
HO-PEG14-OH, identified by its CAS number 1189112-05-7, is a high-purity polyethylene glycol (PEG) derivative widely utilized in pharmaceuticals, biotechnology, and material science. This 14-unit PEG chain terminated with hydroxyl groups at both ends offers exceptional solubility, biocompatibility, and low immunogenicity, making it a cornerstone in drug delivery systems and bioconjugation. Its unique structure enables precise control over molecular weight and functionality, addressing critical challenges in modern research and industrial applications.
The growing demand for PEG-based compounds like HO-PEG14-OH is driven by advancements in nanomedicine and targeted therapy. Researchers frequently search for "PEGylation techniques" or "HO-PEG14-OH solubility," reflecting its role in enhancing drug stability and prolonging circulation time. Recent studies highlight its use in mRNA vaccine formulations, where PEG derivatives stabilize lipid nanoparticles—a topic gaining traction due to global health initiatives. Additionally, its application in 3D bioprinting as a bioink modifier aligns with trends in regenerative medicine.
From a chemical perspective, HO-PEG14-OH (CAS 1189112-05-7) exhibits a molecular weight of approximately 700 Da, with each ethylene oxide unit contributing to its hydrophilic character. This property is pivotal for "aqueous phase reactions" and "protein PEGylation," frequently queried in academic databases. The compound’s low toxicity and FDA-approved status for certain applications further bolster its adoption in cosmetic formulations and medical devices, meeting stringent regulatory standards.
Innovations in green chemistry have also spotlighted HO-PEG14-OH as a sustainable alternative to traditional solvents. Searches for "eco-friendly PEG derivatives" underscore its role in reducing environmental impact while maintaining performance in industrial processes. Furthermore, its compatibility with click chemistry (e.g., azide-alkyne cycloaddition) enables rapid modular synthesis, a technique dominating recent literature on biomaterial engineering.
In summary, HO-PEG14-OH (CAS 1189112-05-7) represents a versatile tool bridging interdisciplinary research. Its alignment with cutting-edge fields like CRISPR delivery systems and theranostic nanoparticles ensures continued relevance. As queries for "PEGylation optimization" and "HO-PEG14-OH suppliers" rise, this compound remains pivotal in translating scientific breakthroughs into tangible solutions.
1189112-05-7 (HO-PEG14-OH) Related Products
- 114740-40-8(2-(2-(2-(2-(2-(2-(2-(2-(2-(2-(2-(2-(2-(2-(2-Methoxyethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethanol)
- 4437-01-8(2,5,8,11,14,17,20-Heptaoxadocosan-22-ol)
- 5137-45-1(Ethylene glycol ethyl methyl ether)
- 2615-15-8(Hexaethylene glycol)
- 103819-45-0(Oils, mink, ethoxylated)
- 3386-18-3(Nonaethylene glycol)
- 38086-00-9(Diglyme-d14)
- 1191-87-3(2,5,8,11,14,17-Hexaoxaoctadecane)
- 133604-58-7(m-PEG16-alcohol)
- 9004-76-6(Tetraethylene glycol)